Lynn Seely, M.D.
Board Member
AbCellera Biologics Inc. (ABCL)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Lynn Seely, M.D.
Lynn Seely, M.D. is recorded as Board Member at AbCellera Biologics Inc. (ABCL). AbCellera Biologics Inc. reported in an 8-K filed July 6, 2026 that Lynn Seely, M.D. was appointed Class III director, effective June 30, 2026.
“On June 30, 2026, the Board of Directors (the "Board") of AbCellera Biologics Inc. (the "Company") appointed Lynn Seely, M.D as a new Class III director.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-06-30–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at AbCellera Biologics Inc.
Other people whose current roles at this company are on record from its filings.
- Andrew Booth CFO
- Ester Falconer CTO
- Véronique Lecault CTO
- Andrew W. Lo Board Member
- John S. Montalbano Board Member
- Stephen Quake, D.Phil. Board Member
- Stephen R. Quake Board Member
- Victor Sandor Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.